awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24594725-21DA4718-00F3-415D-BDB8-1FDC0EA3B5E8
Q24594725-21DA4718-00F3-415D-BDB8-1FDC0EA3B5E8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24594725-21DA4718-00F3-415D-BDB8-1FDC0EA3B5E8
A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab
P2860
Q24594725-21DA4718-00F3-415D-BDB8-1FDC0EA3B5E8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24594725-21DA4718-00F3-415D-BDB8-1FDC0EA3B5E8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
880b199cc0c166a99cd72dacb7b87e7d9b95faf3
P2860
Trastuzumab: triumphs and tribulations.